Navigation Links
GeneLink Reports Denial of Appeal
Date:4/5/2011

ORLANDO, Fla., April 5, 2011 /PRNewswire/ -- GeneLink, Inc. (OTCBB: GNLK, "the Company," or "GeneLink"), a leading consumer genomics biotech company, is pleased to report that by Order dated March 30, 2011, the Supreme Court of Pennsylvania denied the Petition for Allowance of Appeal filed by the Company's former CEO and President, John DePhillipo, and his wife against the Company, its subsidiary GeneWize Life Sciences, Inc., and several of the Company's officers, directors and advisors.  The DePhillipos' petition sought the Supreme Court's reassessment of claims previously dismissed by the Court of Common Pleas of Pennsylvania, Philadelphia County, a dismissal subsequently affirmed by the Superior Court of Pennsylvania.

About GeneLink Biosciences, Inc.:

GeneLink is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer's wellness needs. For more information visit www.genelinkbio.com

This release contains certain forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in the press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement. GeneLink disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE GeneLink, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. David L. Macdonald Appointed CEO of GeneLink BioSciences, Inc.
2. GeneLink Reports First Quarter Gains
3. GeneLink Announces HelixLife Private Label Distribution Agreement
4. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
5. GeneLink Reports Third Quarter Results
6. GeneLink Announces New Licensing Partner
7. GeneLink Reports 2010 Results
8. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
9. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
10. Par Pharmaceutical Reports Second Quarter 2008 Results
11. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... India’s vast and growing population means ... up to a billion dollars per year by ... taking serious action to better regulate and oversee ... will examine:, ,     Recent changes in ... long term impacts ,     Foreseeable opportunities ...
(Date:6/19/2013)... 19, 2013 Express Diagnostics Int’l, Inc., ... announced that it has received Class III medical device ... its DrugCheck® NxStep Onsite Drug Screen Cup ... rapid screening device in near-patient settings, such as physicians’ ... received Health Canada Class III approval for 24 different ...
(Date:6/18/2013)... 2013) A million electric cars could be on roads ... the help of research by the United States Department of ... , Professor Zhongwei Chen is part of a team led ... materials to replace the expensive platinum catalysts in fuel cells. ... fuel cells in vehicles is the cost of the units. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 (PRWEB) June 18, 2013 ... time and attendance system in North America, has ... shares employee data and payroll records between ExakTime’s ... Plus automates ExakTime software setup and keeps ... imports employee data from a business’ current payroll ...
Breaking Biology Technology:Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2ExakTime Introduces AccountLinx Plus 2
... VALLEY COTTAGE, N.Y., March 11 XTL Biopharmaceuticals Ltd. (Nasdaq: ... Extraordinary General Meetings ("EGMs") were postponed for one week in ... of a quorum. The postponed EGMs will take place at ... 76100 at 3:00 p.m. and 5:30 p.m. Israel time on ...
... (NYSE Alternext US: DDD) today reported financial results for ... The Company will host a live conference call ... Time)."Last year was an important period for SCOLR Pharma," ... "Utilizing our unique CDT(R) platforms, we made significant progress ...
... LANSING, Mich., March 11 Neogen Corporation (Nasdaq: ... Neogen Corporation 3rd Quarter Results WebcastWhen: ... http://www.videonewswire.com/event.asp?id=56632 How: Live over the ... at the address above. Contact: Terry ...
Cached Biology Technology:SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 2SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 3SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 4SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 5SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 6SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 7SCOLR Pharma, Inc. Reports Fourth Quarter 2008 Financial Results 8
(Date:6/18/2013)... DNA and this modification can occur in millions ... scientists believed that this epigenetic phenomenon actively reduced ... of researchers from the University of Geneva (UNIGE), ... the Faculty of Medicine, reveals that this is ... may play both a passive and active role ...
(Date:6/17/2013)... have identified a new virus in patients with severe ... determine whether the virus is responsible for the symptoms ... total of 28 out of 644 patients with severe ... but not in any of the 122 patients with ... the brain and central nervous system are often fatal ...
(Date:6/17/2013)... understand the concept of improving original foundations with more ... the University of Pittsburgh,s Kenneth P. Dietrich School of ... that could make drug delivery, gas storage, and gas ... findings were reported in the latest issue of the ... JACS ). , The recent work builds upon Pitt ...
Breaking Biology News(10 mins):The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3'Chemical architects' build materials with potential applications in drug delivery and gas storage 2
... A new University of Central Florida study will examine how ... the Florida Panhandle and Alabama and Mississippi coasts. The ... Civil Engineering, is a response to scientific studies that show ... Hagen,s research also could potentially be linked with models of ...
... free of charge so that customers can neutralise the heart ... suggest in a new study published this week. Statins ... A wealth of trial data has proven them to be ... In a paper published in the Sunday 15 August issue ...
... Mount Sinai School of Medicine, New York, has been ... receive a 2010 ICAAC Young Investigator Award. Sponsored ... an early career scientist for research excellence in microbiology ... postdoctoral training in Molecular Biology at Harvard University in ...
Cached Biology News:Study to examine rising sea level's impact on estuaries, coastal communities 2Free statins with fast food could neutralize heart risk, scientists say 2
... frozen Sf9 Insect Cells are derived from the ... for optimal growth, use in transfections, plaque assays, ... frozen in a protocol that optimizes recovery of ... growth in serum-free BacVector Insect Cell Medium and ...
... software package that provides crystallographers with ... buffer creation, set-up of experimental conditions ... The software helps crystallographers through the ... crystallography: Design of ...
... premium quality recombinant form of Thermus aquaticus ... for a wide range of PCR applications. ... performance, each preparation is extensively tested in ... DNA Polymerase possesses an integral 5′→3′ exonuclease ...
... direct antibiotic-based selection system for recombinant identification. ... eliminating the need for costly color screening. ... to 100% accuracy in recombinant selection. pLivSelect ... colony picking. This cloning kit can be ...
Biology Products: